BREAKING NEWS
Site Under Development, Content Population and SEO, Soft Launch 1st January 2020
The Pap smear test is a helpful screening tool to detect changes in the cells of the cervix that may have the potential to lead to cervical cancer. This aids in recognizing changes earlier and allows treatment to help prevent the progression to cervical cancer.
It is recommended for all women over the age of 18 that have ever been sexually active to have regular Pap smears every two years.
The test involves a cell sample being taken from the cervical wall. This smear is then sent away to a laboratory to be tested for abnormalities associated with HPV and cervical cancer.
A glass slide is used to collect the cells and the Papanicolaou technique is used in the laboratory to detect abnormal cells. This involves staining of the sample cells with tinctorial dyes, which leads selective cells to retain the acides.
Observing the way in which the cells react to the dye allows medical analysts to detect if the cells normal or abnormal.
If normal results are detected, the woman should be advised that the cells in her cervix are normal at the current time but she should return for another test in two years time to continue monitoring the cervical cells.
It is also possible for the results to be unclear as to whether the cell sample is normal or abnormal. In most cases, this will lead to another Pap test after a shorter period of time than the standard recommendation to monitor further changes. Further tests can also be undertaken immediately in some cases to examine the possibility of the more serious outcomes.
There are several different classes of abnormal Pap smear results.
ASCUS or AGUS refers to abnormal cells without a clear explanation of what the changes signify. They may be due to HPV but may also be indicative of changes that lead to cancer.
Low or high-grade dysplasia (LSIL or HSIL) suggests that there are changes present that have the potential to lead to cancer. This risk is more prominent with HSIL.
Carcinoma in situ (CIS) usually means that there are abnormal changes present that are likely to require treatment to avoid progression to cervical cancer.
Atypical squamous or glandular cells (ASC or AGC) signify abnormal cell changes that may be high-grade dysplasia and require further testing and medical attention.
When any type of abnormal change is found as a result of a Pap smear, further testing is required to investigate the cell changes and the implications this may have.
The course of action in regards to follow up depends on the cell abnormality, as well as the previous history of Pap smears and the family history or other individual risk factors for cervical cancer.
If minor changes are evident, another Pap smear is usually recommend in 6 to 12 months to monitor any further changes to the cells.
A colposcopy-directed biopsy may also be indicated to investigate the current situation further, particular if more severe changes are present. A HPV test is also use to investigate the presence of the HPV viruses commonly associated with causing cervical cancer.
It is essential that the woman is involved in the follow-up process and she understands the implications of each of the tests. Empowering her with information about the follow-up process helps to ensure that she on board with successive treatment decisions.